Bacteriological Water Quality in the Central Dialysis Fluid Delivery System from the Survey of the Japanese Society for Dialysis Therapy

被引:20
作者
Masakane, Ikuto [1 ,2 ]
Takemoto, Yoshiaki [3 ]
Nakai, Shigeru [2 ]
Tsubakihara, Yoshiharu [2 ]
Akiba, Takashi [2 ]
Watanabe, Yuzo [2 ]
Iseki, Kunitoshi [2 ]
机构
[1] Yabuki Shima Clin, Osaka, Japan
[2] Japanese Soc Dialysis Therapy, Patient Registrat Comm, Osaka, Japan
[3] Osaka City Univ, Osaka 558, Japan
关键词
Central dialysis fluid delivery system; JSDT survey; Bacteriological water quality; One-year survival; ULTRAPURE DIALYSATE; HEMODIALYSIS; ASSOCIATION;
D O I
10.1159/000213491
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
The Japanese Society for Dialysis Therapy (JSDT) surveyed all dialysis facilities for bacteriological quality of dialysis fluid and quality controls for dialysis fluid in 2006 and 2007. The JSDT collected the data for endotoxin (ET) levels, bacterial count and usage of ET retentive filters (ETRF). The JSDT standard for ET level in dialysis fluid (<0.050 EU/ml) was achieved in 89.0% in 2006 and in 93.6% in 2007. The JSDT standard for bacterial cell counts in dialysis fluid (<100 cfu/ml) was achieved in 96.9% in 2006 and in 97.4% in 2007. The central dialysis fluid delivery system (CDDS) is a unique system developed in Japan which has easy handling for daily maintenance of delivery systems, but it has been pointed out that CDDS has a weak point for the protection of biofilms. However, the bacteriological water qualities of dialysis fluid in CDDS were proven to be extremely high in most Japanese dialysis facilities by JSDT surveys. Bacteriological water quality has a strong impact on the patient outcome. The acceptable level of ET of dialysis fluid should be <0.1 EU/ml based on the results of JSDT survey. The excellent water quality in CDDS might be one of the important factors which help good patient survival in chronic dialysis in Japan. Copyright (C) 2009 S. Karger AG, Basel
引用
收藏
页码:11 / 16
页数:6
相关论文
共 16 条
[1]
[Anonymous], 2002, NEPHROL DIAL TRAN S7, V17, P45
[2]
*ASS ADV MED INSTR, 2005, RD52 ANSIAAMI
[3]
USING ULTRAPURE WATER IN HEMODIALYSIS DELAYS CARPAL-TUNNEL SYNDROME [J].
BAZ, M ;
DURAND, C ;
RAGON, A ;
JABER, K ;
ANDRIEU, D ;
MERZOUK, T ;
PURGUS, R ;
OLMER, M ;
REYNIER, JP ;
BERLAND, Y .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1991, 14 (11) :681-685
[4]
Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: The dialysis outcomes and practice patterns study (DOPPS) [J].
Goodkin, DA ;
Bragg-Gresham, JL ;
Koenig, KG ;
Wolfe, RA ;
Akiba, T ;
Andreucci, VE ;
Saito, A ;
Rayner, HC ;
Kurokawa, K ;
Port, FK ;
Held, PJ ;
Young, EW .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (12) :3270-3277
[5]
Hasegawa T, 2008, J AM SOC NEPHROL, V19, p70A
[6]
*ISO DIS, 2008, 11663 ISODIS
[7]
Kawanishi H, 2005, J JPN SOC DIAL THER, V38, P149
[8]
Standard on Microbiological Management of Fluids for Hemodialysis and Related Therapies by the Japanese Society for Dialysis Therapy 2008 [J].
Kawanishi, Hideki ;
Akiba, Takashi ;
Masakane, Ikuto ;
Tomo, Tadashi ;
Mineshima, Michio ;
Kawasaki, Tadayuki ;
Hirakata, Hideki ;
Akizawa, Tadao .
THERAPEUTIC APHERESIS AND DIALYSIS, 2009, 13 (02) :161-166
[9]
Defining the microbiological quality of dialysis fluid [J].
Ledebo, I ;
Nystrand, R .
ARTIFICIAL ORGANS, 1999, 23 (01) :37-43
[10]
Masakane I, 2008, J AM SOC NEPHROL, V19, p693A